Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$32.08 -0.7 | -2.14%
10/08/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 32.78
52 Week High 51.99
52 Week Low 22.04
Avg. Daily Vol. (Mil) 1.34
Beta (3 year) 3.07
Share Related Items
Mkt Cap (Mil) 3,301.43
Shares Out (Mil) 100.71
Float (Mil) 64.63
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 14.10
Current Ratio 14.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 48.55K
Price/Book 12.91
Price/Cash Flow -24.80
Per Share Data
Earnings -1.34
Sales 0.00
Book Value 2.54
Cash Flow -1.32
Business Summary
ACADIA Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the business of development and commercialization of small molecule drugs for the treatment of central nervous system disorders.
General Information
11085 Torreyana Road
Suite 100
San Diego, CA 92121
Industry : Drugs
Sector: Health Care
Employees: 136
CEO: Mr. Stephen R. Davis
Short Interest
Current Month (Mil) 15.00
Previous Month (Mil) 14.11
Short Interest Ratio (Days) 12.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -48.20
Return on Investments -52.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases

Partner Headlines for ACAD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter